News
-
An important victory for fashion designers
19 June 2014Read more >Following a long standing legal challenge, the Court of Justice of the European Union (CJEU) has today sided with Karen Millen in a ruling which should offer greater protection for designers in future. The dispute between the high-end, high street retailer and the Irish department store, Dunnes, centres on the design of a black jumper […]
-
Are supplementary protection certificates for medical devices on the horizon?
18 June 2014Read more >A recent decision of the UKIPO Hearing Office (see here) has added to the growing body of case law concerning which products are, and which are not, entitled to a Supplementary Protection Certificate (SPC). Those familiar with the pharmaceutical sector will be aware that SPCs provide an extension to the lifetime of patent monopolies for […]
-
Intellectual property bill receives royal assent
15 May 2014Read more >The Intellectual Property Bill received royal assent on 15 May 2014, and will come into force as the Intellectual Property Act 2014. Many of the new measures are expected to take effect in October 2014, with the remainder entering into force by the end of 2015. Designs are a key focus for the new legislation. […]
-
The Intellectual Property Enterprise Court (IPEC) The UK’s Cost-Effective Venue for Litigation in Europe
17 April 2014Read more >The UK has a reputation for litigation to be extremely expensive, lengthy and complicated. As a result, many companies have chosen to litigate their patents in Germany, where it is perceived that litigation is cheaper and quicker. This article aims to demonstrate that patent litigation in the UK can be just as inexpensive as it […]
-
Evidence Unscrambled: SCRABBLE Unsuccessful in Trade Mark Dispute at UK High Court
17 April 2014Read more >On 1 November 2013, the High Court of England and Wales issued its decision in the case of JW Spear & Sons Ltd & Mattel. Inc. v Zynga, Inc [2013] EWHC 3348 (Ch). The High Court decided that Zynga’s online game, SCRAMBLE WITH FRIENDS, does not infringe Mattel’s rights in its famous SCRABBLE mark, except […]
-
The Australian High Court Upholds Patentability of Methods of Medical Treatment in Apotex v Sanofi-Aventis
16 April 2014Read more >This case concerned Apotex’s generic version of Sanofi-Aventis’ leflunomide drug, ARAVA®. Sanofi-Aventis obtained a patent which claims: “A method of preventing or treating a skin disorder, wherein the skin disorder is psoriasis, which comprises administering to a recipient an effective amount of [leflunomide]”. Leflunomide is used in Australia to treat psoriatic arthritis and rheumatoid arthritis, […]
